“…Although the causal relationship between inflammation, innate immunity and cancer is more widely accepted, many of the molecular and cellular mechanisms mediating this relationship remain unresolved (Coussens and Werb, 2002). Many studies have implicated Nrf2 (Nfe2l2) in cancer (Ramos-Gomez et al, 2001;Katsuoka et al, 2005;Sporn and Liby, 2005;Nair et al, 2007a;Pearson et al, 2008) or inflammation-associated diseases such as colitis (Khor et al, 2006;Osburn et al, 2007), and Parkinson's disease (Clements et al, 2006), and NF-kB in inflammation (Muller-Ladner et al, 2002;Profita et al, 2008;Puthia et al, 2008) and cancer Cilloni et al, 2006;Sun and Zhang, 2007;McDonnell et al, 2008). Indeed, the identification of combinatorial, or synergistic, transcription factors and the elucidation of relationships among them are of great importance for understanding transcriptional regulation as well as transcription factor networks (Hu et al, 2007).…”